How to deal with unexpected cardiac troponin results
Eur Heart J Acute Cardiovasc Care
.
2022 Jun 7;11(4):e1-e3.
doi: 10.1093/ehjacc/zuac023.
Authors
Johannes Mair
1
,
Evangelos Giannitsis
2
,
Nicholas L Mills
3
4
,
Christian Mueller
5
;
Study Group on Biomarkers of the European Society of Cardiology Association for Acute CardioVascular Care
Collaborators
Study Group on Biomarkers of the European Society of Cardiology Association for Acute CardioVascular Care
:
Bertil Lindahl
,
Louise Cullen
,
Ola Hammarsten
,
Kurt Huber
,
Allan S Jaffe
,
Konstantin Krychtiuk
,
Martin Möckel
,
Kristian Thygesen
Affiliations
1
Department of Internal Medicine III-Cardiology and Angiology, Medical University Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
2
Department of Cardiology, Heidelberg University, Heidelberg, Germany.
3
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
4
Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
5
Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
PMID:
35218650
DOI:
10.1093/ehjacc/zuac023
No abstract available
MeSH terms
Biomarkers
Humans
Troponin I*
Troponin T*
Substances
Biomarkers
Troponin I
Troponin T
Grants and funding
CH/F/21/90010/BHF_/British Heart Foundation/United Kingdom